298 related articles for article (PubMed ID: 30454053)
21. Placenta accreta in a patient with Asherman's syndrome.
Beard RM
Aust N Z J Obstet Gynaecol; 1966 Nov; 6(4):316-20. PubMed ID: 5232203
[No Abstract] [Full Text] [Related]
22. Asherman's syndrome and risk of placenta accreta.
Dmowski WP; Greenblatt RB
Obstet Gynecol; 1969 Aug; 34(2):288-99. PubMed ID: 5816312
[No Abstract] [Full Text] [Related]
23. Classification systems of Asherman's syndrome. An old problem with new directions.
Manchanda R; Rathore A; Carugno J; Della Corte L; Tesarik J; Török P; Vilos GA; Vitale SG
Minim Invasive Ther Allied Technol; 2021 Oct; 30(5):304-310. PubMed ID: 33660561
[TBL] [Abstract][Full Text] [Related]
24. The value of MRI in the assessment of traumatic intra-uterine adhesions (Asherman's syndrome).
Bacelar AC; Wilcock D; Powell M; Worthington BS
Clin Radiol; 1995 Feb; 50(2):80-3. PubMed ID: 7867273
[TBL] [Abstract][Full Text] [Related]
25. Management of Asherman's syndrome.
March CM
Reprod Biomed Online; 2011 Jul; 23(1):63-76. PubMed ID: 21549641
[TBL] [Abstract][Full Text] [Related]
26. [The role of hysteroscopy in the diagnosis and treatment of uterine adhesions. Apropos of 15 cases].
Cisse CT; Andriamampandry SD; Diallo Y; Diab EH; Diadhiou F
Rev Fr Gynecol Obstet; 1995 Jan; 90(1):17-21. PubMed ID: 7899766
[TBL] [Abstract][Full Text] [Related]
27. [Asherman's syndrome : management after curettage following a postnatal placental retention and literature review].
Tchente NC; Brichant G; Nisolle M
Rev Med Liege; 2018 Oct; 73(10):508-512. PubMed ID: 30335256
[TBL] [Abstract][Full Text] [Related]
28. Successful pregnancy outcome after hysteroscopic adhesiolysis in Asherman's syndrome.
Fletcher H; Kulkarni S; Brown E
West Indian Med J; 1997 Dec; 46(4):124-5. PubMed ID: 9494408
[TBL] [Abstract][Full Text] [Related]
29. Hysteroscopic Management of Asherman's Syndrome.
Khan Z; Goldberg JM
J Minim Invasive Gynecol; 2018 Feb; 25(2):218-228. PubMed ID: 29024798
[TBL] [Abstract][Full Text] [Related]
30. Clinical application of stage operation in patients with placenta accreta after previous caesarean section.
Peng Q; Zhang W; Liu Y
Medicine (Baltimore); 2018 Jun; 97(22):e10842. PubMed ID: 29851793
[TBL] [Abstract][Full Text] [Related]
31. Intrauterine adhesions.
Berman JM
Semin Reprod Med; 2008 Jul; 26(4):349-55. PubMed ID: 18756412
[TBL] [Abstract][Full Text] [Related]
32. Conservative Surgical Treatment of a Case of Placenta Accreta.
Biyik I; Keskin F; Keskin EU
Rev Bras Ginecol Obstet; 2018 Aug; 40(8):494-496. PubMed ID: 30142668
[TBL] [Abstract][Full Text] [Related]
33. Effects of uterus derived mesenchymal stem cells and their exosomes on asherman's syndrome.
Saribas GS; Ozogul C; Tiryaki M; Alpaslan Pinarli F; Hamdemir Kilic S
Acta Histochem; 2020 Jan; 122(1):151465. PubMed ID: 31776004
[TBL] [Abstract][Full Text] [Related]
34. Bone Marrow-Derived Stem Cell (BMDSC) transplantation improves fertility in a murine model of Asherman's syndrome.
Alawadhi F; Du H; Cakmak H; Taylor HS
PLoS One; 2014; 9(5):e96662. PubMed ID: 24819371
[TBL] [Abstract][Full Text] [Related]
35. Uterine body placenta accreta spectrum: A detailed literature review.
Badr DA; Al Hassan J; Salem Wehbe G; Ramadan MK
Placenta; 2020 Jun; 95():44-52. PubMed ID: 32452401
[TBL] [Abstract][Full Text] [Related]
36. Persistent placenta increta: a complication of conservative management of presumed placenta accreta.
Davis JD; Cruz A
Obstet Gynecol; 1996 Oct; 88(4 Pt 2):653-4. PubMed ID: 8841240
[TBL] [Abstract][Full Text] [Related]
37. Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis.
Javinani A; Qaderi S; Hessami K; Shainker SA; Shamshirsaz AA; Fox KA; Mustafa HJ; Subramaniam A; Khandelwal M; Sandlin AT; Duzyj CM; Lyell DJ; Zuckerwise LC; Newton JM; Kingdom JC; Harrison RK; Shrivastava VK; Greiner AL; Loftin R; Genc MR; Atasi LK; Abdel-Razeq SS; Bennett KA; Carusi DA; Einerson BD; Gilner JB; Carver AR; Silver RM; Shamshirsaz AA
Am J Obstet Gynecol; 2024 May; 230(5):485-492.e7. PubMed ID: 37918506
[TBL] [Abstract][Full Text] [Related]
38. [Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases].
Daney de Marcillac F; Lecointre L; Guillaume A; Sananes N; Fritz G; Viville B; Boudier E; Nisand I; Gaudineau A; Langer B; Akladios CY
J Gynecol Obstet Biol Reprod (Paris); 2016 Oct; 45(8):849-858. PubMed ID: 27118678
[TBL] [Abstract][Full Text] [Related]
39. Asherman's Syndrome after Uterine Artery Embolization: A Case of Embolic Spheres Displacement inside the Uterine Cavity.
Gubbini G; Bertapelle G; Bosco M; Zorzato PC; Uccella S; Favilli A
J Minim Invasive Gynecol; 2021 Aug; 28(8):1436-1437. PubMed ID: 33744406
[No Abstract] [Full Text] [Related]
40. Uterine conservation despite severe sepsis in a case of placenta accreta first treated conservatively: 3-month delayed successful removal of the placenta.
Morel O; Desfeux P; Fargeaudou Y; Malartic C; Rossignol M; Perrotez C; Barranger E
Fertil Steril; 2009 May; 91(5):1957.e5-9. PubMed ID: 19304286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
